Bullish option flow detected in TG Therapeutics with 1,627 calls trading, 1.0x expected, and implied vol increasing over 17 points to 222.89%. Jan-23 8 calls and Jan-23 15 calls are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.28. Earnings are expected on February 28th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TGTX:
- Cellectar Biosciences appoints Lea as Chief Commercial Officer
- Here’s Why TG Therapeutics Shares (NASDAQ: TGTX) Surged Over 60%
- TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
- TG Therapeutics to Host Conference Call on Third Quarter 2022 Financial Results and Business Update
- TG Therapeutics Announces Presentation of Exploratory Analyses from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis Presented at the 2022 European Committee for Treatment and Research in Multiple Sclerosis